Equities

Beijing Balance Medical Technology Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Beijing Balance Medical Technology Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)101.66
  • Today's Change-1.53 / -1.48%
  • Shares traded527.01k
  • 1 Year change-4.31%
  • Beta1.0512
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Beijing Balance Medical Technology Co Ltd is a China-based company primarily engaged in the research, development, production and sales of artificial bio-valves, animal-derived implantable materials, and implantable artificial bio-repair products. The Company’s main products include artificial bio-heart valves-bovine pericardial valves, annuloplasty rings, cardiac surgical bio-patterns, outflow tract single valve patches, heart valve bio-patterns, neurosurgical bio-patterns and others. The Company’s products are mainly used in the fields of structural heart disease and soft tissue repair. The Company mainly conducts its business in the domestic market.

  • Revenue in CNY (TTM)591.28m
  • Net income in CNY180.33m
  • Incorporated2005
  • Employees611.00
  • Location
    Beijing Balance Medical Technology Co LtdNo.2, Huachang Road, Scienceand Technology Park East Zone, ChangpinBeijing 102200ChinaCHN
  • Phone+86 1 060735920
  • Fax+86 1 089700424
  • Websitehttps://www.balancemed.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Beijing Wandong Medical Technolgy Co Ltd1.62bn14.41m11.31bn1.19k965.792.42--6.980.01670.01672.266.660.29372.732.991,360,016.000.26234.510.3045.2131.5942.820.893314.914.80--0.003943.2523.269.18-16.54-1.40-1.3921.06
Sansure Biotech Inc1.67bn271.49m11.59bn2.35k45.181.63--6.940.44270.44272.4512.310.18521.042.46711,687.902.5021.182.8124.3773.7068.6013.4940.514.49--0.171625.7444.7831.89-24.2347.5065.28--
TINAVI Medical Technologies Co Ltd274.20m-159.01m11.60bn307.00--9.29--42.31-0.3493-0.34930.60352.740.16732.187.63893,155.40-10.37-8.02-11.54-9.1670.0969.64-62.01-63.512.94-15.750.1408---14.85-4.8722.54--12.71--
Eyebright Medical Technlgy (Bjng) Co Ltd1.48bn360.97m11.67bn2.29k32.054.15--7.891.881.887.7114.530.40481.893.34644,799.409.9010.5011.5412.0462.9175.1324.4531.923.2824.660.175320.1148.2448.5127.7742.2518.40--
Shandong Weigao Orthopaedic Devce Co Ltd1.48bn266.86m11.93bn2.07k44.712.93--8.090.66720.66723.7010.180.29190.77985.17714,278.405.369.006.5811.0564.2274.0718.3724.984.28--0.001122.9013.18-1.5999.22-12.72-3.40--
Vcanbio Cell & Gene Engineering Corp Ltd1.47bn74.75m12.09bn2.01k156.853.26--8.210.16470.16473.297.930.27781.922.35730,874.401.071.241.511.7667.2968.073.854.201.604.900.02190.00-0.27052.71-5.7315.09-11.35--
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.25bn377.82m12.20bn832.0031.783.08--9.753.123.1210.2732.100.26941.563.661,515,185.007.9415.389.1016.8768.1075.3829.4541.854.36--0.004346.521.6129.301.9628.7858.5335.76
Beijing Hotgen Biotech Co Ltd434.45m-259.33m13.37bn903.00--4.56--30.77-3.04-3.044.9831.630.13131.964.23481,114.30-7.9721.79-8.4724.9356.3855.43-60.7129.144.77--0.016844.35-6.7419.41-760.40---10.29--
Beijing Balance Medical Technolgy Co Ltd591.28m180.33m14.21bn611.0078.7311.41--24.041.311.314.299.040.42681.275.08967,721.8011.938.0312.978.4486.7888.9327.9527.672.89--0.066876.3235.4128.0127.0218.33140.7741.14
Micro-Tech Nanjing Co Ltd3.12bn611.40m15.47bn2.46k25.253.80--4.953.263.2616.6521.680.64011.936.361,267,666.0013.0010.5615.9312.6164.0963.4620.3019.113.30--0.062633.6514.2616.0813.8512.7538.21--
Shandong Weigao Bld Prfctn Prdcts Co Ltd3.70bn474.39m16.92bn3.48k36.612.42--4.581.111.118.5216.71------1,060,956.00--------39.57--12.84--2.62--0.0007--2.03--1.65------
Data as of Feb 11 2026. Currency figures normalised to Beijing Balance Medical Technology Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

6.25%Per cent of shares held by top holders
HolderShares% Held
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20254.53m3.32%
Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 20251.59m1.16%
Bosera Asset Management Co., Ltd.as of 30 Sep 2025691.04k0.51%
Truvalue Asset Management Co. Ltd.as of 30 Jun 2025483.66k0.35%
The Vanguard Group, Inc.as of 07 Jan 2026346.99k0.25%
Penghua Fund Management Co., Ltd.as of 30 Jun 2025304.65k0.22%
China Asset Management Co., Ltd.as of 30 Jun 2025196.75k0.14%
Yinhua Fund Management Co., Ltd.as of 30 Jun 2025145.15k0.11%
Rongtong Fund Management Co., Ltd.as of 30 Jun 2025141.37k0.10%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025111.51k0.08%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.